1. |
Konstantinou G, Stavrinou A, Mylona S, et al. Basal ganglia calcification: a case report of fahr disease with pure psychiatric symptoms. J Psychiatr Pract, 2019, 25(5): 391-394.
|
2. |
Mandal A, Patel NB, Missouris CG. Sepsis unmasking fahr's disease. Am J Med Sci, 2020, 360(4): 406-409.
|
3. |
Batla A, Tai XY, Schottlaender L, et al. Deconstructing Fahr's disease/syndrome of brain calcification in the era of new genes. Parkinsonism Relat Disord, 2017, 37: 1-10.
|
4. |
Peters M, de Brouwer E, Bartstra JW, et al. Mechanisms of calcification in Fahr disease and exposure of potential therapeutic targets. Neurol Clin Pract, 2020, 10(5): 449-457.
|
5. |
Sekine SI, Nishii K, Masaka T, et al. SLC20A2 variants cause dysfunctional phosphate transport activity in endothelial cells induced from Idiopathic Basal Ganglia Calcification patients-derived iPSCs. Biochem Biophys Res Commun, 2019, 510(2): 303-308.
|
6. |
Subedi S, Mukhi S, Pandey P. Fahr's disease presenting with manic symptoms. JNMA J Nepal Med Assoc, 2018, 56(209): 553-555.
|
7. |
Mu W, Tochen L, Bertsch C, et al. Intracranial calcifications and dystonia associated with a novel deletion of chromosome 8p11. 2 encompassing SLC20A2 and THAP1. BMJ Case Rep, 2019, 12(5): e228782.
|
8. |
Wang H, Shao B, Wang L, et al. Fahr's disease in two siblings in a family: A case report. Exp Ther Med, 2015, 9(5): 1931-1933.
|
9. |
Mufaddel AA, Al-Hassani GA. Familial idiopathic basal ganglia calcification (Fahr`s disease). Neurosciences (Riyadh), 2014, 19(3): 171-177.
|
10. |
Donzuso G, Mostile G, Nicoletti A, et al. Basal ganglia calcifications (Fahr's syndrome): related conditions and clinical features. Neurol Sci, 2019, 40(11): 2251-2263.
|
11. |
Valdes HMC, Glatz A, Kiker AJ, et al. Differentiation of calcified regions and iron deposits in the ageing brain on conventional structural MR images. J Magn Reson Imaging, 2014, 40(2): 324-333.
|